Literature DB >> 16427831

Ex vivo evaluation of nonacceptable donor lungs.

Per Wierup1, Asa Haraldsson, Folke Nilsson, Leif Pierre, Henrik Scherstén, Martin Silverborn, Trygve Sjöberg, Ulla Westfeldt, Stig Steen.   

Abstract

BACKGROUND: Only a minority of the potential candidates for lung donation are considered suitable, using current evaluation methods. A new method for ex vivo evaluation, with the potential for reconditioning of marginal and nonacceptable lungs, has been developed. This is a report of the ex vivo evaluation of six donor lungs deemed nonacceptable (arterial oxygen pressure less than 40 kPa) by the Scandiatransplant, Eurotransplant, and UK transplant organizations.
METHODS: The lungs are perfused ex vivo with Steen solution, a lung evaluation-preservation solution, mixed with red blood cells to a hematocrit of 15%. This extracellular solution is designed to have an optimal colloid osmotic pressure so that physiologic pressure and flow can be maintained without development of pulmonary edema. An oxygenator connected to the extracorporeal circuit maintains a normal mixed venous blood gas level in the perfusate. The lungs are ventilated and evaluated through analyses of pulmonary vascular resistance, oxygenation capacity, and arterial carbon dioxide pressure minus end-tidal carbon dioxide difference.
RESULTS: The arterial oxygen pressure (inspired oxygen fraction, 1.0) increased from 27 kPa (range, 17 to 34 kPa) in situ in the organ donor at the referring hospital to 57 kPa (range, 39 to 66 kPa) during the ex vivo evaluation. The pulmonary vascular resistance varied from 3.2 to 5.7 Wood units, and the arterial carbon dioxide pressure minus end-tidal carbon dioxide difference was in the range of 1 to 2.5 kPa.
CONCLUSIONS: The arterial oxygen pressure improves significantly in this model. This ex vivo evaluation model is a valuable addition to the armamentarium in finding acceptable lungs in a donor population with inferior arterial oxygen pressure values.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16427831     DOI: 10.1016/j.athoracsur.2005.08.015

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  29 in total

Review 1.  Bioengineering approaches to organ preservation ex vivo.

Authors:  Meghan Pinezich; Gordana Vunjak-Novakovic
Journal:  Exp Biol Med (Maywood)       Date:  2019-03-19

2.  Comparison of normothermic and hypothermic perfusion in porcine kidneys donated after cardiac death.

Authors:  Matthew F Blum; Qiang Liu; Basem Soliman; Paul Dreher; Toshihiro Okamoto; Emilio D Poggio; David A Goldfarb; William M Baldwin; Cristiano Quintini
Journal:  J Surg Res       Date:  2017-04-20       Impact factor: 2.192

3.  How to establish a successful ex vivo lung perfusion program.

Authors:  George Makdisi; Thomas C Wozniak
Journal:  Ann Transl Med       Date:  2017-05

Review 4.  Application of ex vivo lung perfusion (EVLP) in lung transplantation.

Authors:  Xufeng Pan; Jun Yang; Shijie Fu; Heng Zhao
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

5.  Adenosine A₂A agonist improves lung function during ex vivo lung perfusion.

Authors:  Abbas Emaminia; Damien J Lapar; Yunge Zhao; John F Steidle; David A Harris; Victor E Laubach; Joel Linden; Irving L Kron; Christine L Lau
Journal:  Ann Thorac Surg       Date:  2011-10-31       Impact factor: 4.330

6.  Cell replacement in human lung bioengineering.

Authors:  Brandon A Guenthart; John D O'Neill; Jinho Kim; Kenmond Fung; Gordana Vunjak-Novakovic; Matthew Bacchetta
Journal:  J Heart Lung Transplant       Date:  2018-11-22       Impact factor: 10.247

Review 7.  Organ preservation: from the past to the future.

Authors:  Lei Jing; Leeann Yao; Michael Zhao; Li-Ping Peng; Mingyao Liu
Journal:  Acta Pharmacol Sin       Date:  2018-03-22       Impact factor: 6.150

8.  Human models of acute lung injury.

Authors:  Alastair G Proudfoot; Danny F McAuley; Mark J D Griffiths; Matthew Hind
Journal:  Dis Model Mech       Date:  2011-03       Impact factor: 5.758

9.  A physiologic and biochemical profile of clinically rejected lungs on a normothermic ex vivo lung perfusion platform.

Authors:  Timothy J George; George J Arnaoutakis; Claude A Beaty; Simran K Jandu; Lakshmi Santhanam; Dan E Berkowitz; Ashish S Shah
Journal:  J Surg Res       Date:  2012-11-27       Impact factor: 2.192

10.  Novel critical role of Toll-like receptor 4 in lung ischemia-reperfusion injury and edema.

Authors:  Giorgio Zanotti; Monica Casiraghi; John B Abano; Jason R Tatreau; Mayura Sevala; Hilary Berlin; Susan Smyth; William K Funkhouser; Keith Burridge; Scott H Randell; Thomas M Egan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-04-17       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.